BioinksBioprintingProduct Launch

BIO INX and Readily3D collaborate on bioinks for volumetric bioprinting

Gel-MA based READYGEL INX will be the first product, designed for high reproducibility and performance

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

BIO INX, a leader in bioink technologies has formed a strategic partnership with Readily3D, developer of high-resolution volumetric 3D printers, to introduce new biomaterials for volumetric 3D bioprinting. The first commercially available bioink is a state-of-the-art, gel-MA-based ink, dubbed READYGEL INX and designed for high reproducibility and unparalleled performance in volumetric bioprinting applications.

This pioneering ink, which is delivered sterile and ready to use, represents the first of a volumetric ink portfolio that will revolutionize the field of bioprinting. Developed to make the user experience as straightforward as possible, READYGEL INX follows BIO INX’s “plug and print” principle, with preoptimized processing parameters streamlining the bioprinting process and empowering researchers with unprecedented ease of use. READYGEL INX is available from BIO INX for the Readily 3D volumetric system with a price tag of €290 for a 10 ml vial.

BIO INX and Readily3D collaborate on bioinks for volumetric bioprinting, with Gel-MA based READYGEL INX as their the first product

Volumetric printing, a lightning-fast tomographic printing technology, holds the promise of printing structures within seconds, opening a new era of opportunities for clinical applications. “Thanks to the speed of this technology, with the newly developed highly biocompatible resin, the futuristic idea of harvesting cells, printing directly alongside the patient in the operating room prior to reimplantation becomes an attainable reality,” said Coralie Gréant, COO at BIO INX.

By leveraging tomographic 3D printing, which rapidly solidifies photosensitive inks in three dimensions using shaped light beams from multiple angles, centimeter-scale biological systems with microscale resolution can be produced in mere seconds. Importantly, the light-based nature of this printing method ensures minimal shear stress on printed cells, with a low light dose (<600 mJ/cm²), making it exceptionally cell- and organoid-friendly.

CEO of BIO INX, Jasper Van Hoorick, stated: “This collaboration perfectly aligns with our vision of bringing bioprinting technology to clinics within the next decade. Prioritizing standardization, reproducibility, and ‘turn-key’ bioprinting solutions, volumetric bioprinting marks a substantial advancement toward achieving these goals.”

Launching this new portfolio with READYGEL INX, a Gel-MA-based resin, comes as no surprise, given that BIO INX originates from the cradle of Gel-MA as a spin-off company from the research group where An Van Den Bulcke first published Gel-MA in the year 2000. This research group is currently co-led by Prof. Sandra Van Vlierberghe, cofounder of BIO INX. The extensive gelatin expertise at BIO INX is further exemplified by the recent partnership with Rousselot for the distribution of GMP-ready X-pure gelatins.

Paul Delrot, CEO of Readily3D, added: “Partnering with a reputable supplier of reproducible light-based bioinks aligns with our commitment to delivering comprehensive solutions to our customers. By combining materials with high-reproducibility and high-performance systems, we are accelerating the journey towards clinical applications of bioprinting.”

The collaboration between BIO INX and Readily 3D promises to propel the field of bioprinting forward, offering researchers and clinicians groundbreaking solutions to address the challenges of modern healthcare and regenerative medicine.

Research
Composites AM 2024

746 composites AM companies individually surveyed and studied. Core composites AM market generated over $785 million in 2023. Market expected to grow to $7.8 billion by 2033 at 25.8% CAGR. This new...

Davide Sher

Since 2002, Davide has built up extensive experience as a technology journalist, market analyst and consultant for the additive manufacturing industry. Born in Milan, Italy, he spent 12 years in the United States, where he completed his studies at SUNY USB. As a journalist covering the tech and videogame industry for over 10 years, he began covering the AM industry in 2013, first as an international journalist and subsequently as a market analyst, focusing on the additive manufacturing industry and relative vertical markets. In 2016 he co-founded London-based VoxelMatters. Today the company publishes the leading news and insights websites VoxelMatters.com and Replicatore.it, as well as VoxelMatters Directory, the largest global directory of companies in the additive manufacturing industry.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Save
Accept all Services

Newsletter

Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.